Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C29H32O13 |
Molecular Weight | 588.5566 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 10 / 10 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@]12COC(=O)[C@]1([H])[C@H](C3=CC(OC)=C(O)C(OC)=C3)C4=CC5=C(OCO5)C=C4[C@H]2O[C@]6([H])O[C@]7([H])CO[C@@H](C)O[C@@]7([H])[C@H](O)[C@H]6O
InChI
InChIKey=VJJPUSNTGOMMGY-MRVIYFEKSA-N
InChI=1S/C29H32O13/c1-11-36-9-20-27(40-11)24(31)25(32)29(41-20)42-26-14-7-17-16(38-10-39-17)6-13(14)21(22-15(26)8-37-28(22)33)12-4-18(34-2)23(30)19(5-12)35-3/h4-7,11,15,20-22,24-27,29-32H,8-10H2,1-3H3/t11-,15+,20-,21-,22+,24-,25-,26-,27-,29+/m1/s1
Molecular Formula | C29H32O13 |
Molecular Weight | 588.5566 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 10 / 10 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:34:11 UTC 2023
by
admin
on
Fri Dec 15 15:34:11 UTC 2023
|
Record UNII |
6PLQ3CP4P3
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NDF-RT |
N0000175609
Created by
admin on Fri Dec 15 15:34:11 UTC 2023 , Edited by admin on Fri Dec 15 15:34:11 UTC 2023
|
||
|
NDF-RT |
N0000000176
Created by
admin on Fri Dec 15 15:34:11 UTC 2023 , Edited by admin on Fri Dec 15 15:34:11 UTC 2023
|
||
|
WHO-VATC |
QL01CB01
Created by
admin on Fri Dec 15 15:34:11 UTC 2023 , Edited by admin on Fri Dec 15 15:34:11 UTC 2023
|
||
|
WHO-ESSENTIAL MEDICINES LIST |
8.2
Created by
admin on Fri Dec 15 15:34:11 UTC 2023 , Edited by admin on Fri Dec 15 15:34:11 UTC 2023
|
||
|
NCI_THESAURUS |
C1331
Created by
admin on Fri Dec 15 15:34:11 UTC 2023 , Edited by admin on Fri Dec 15 15:34:11 UTC 2023
|
||
|
LIVERTOX |
NBK548102
Created by
admin on Fri Dec 15 15:34:11 UTC 2023 , Edited by admin on Fri Dec 15 15:34:11 UTC 2023
|
||
|
WHO-ATC |
L01CB01
Created by
admin on Fri Dec 15 15:34:11 UTC 2023 , Edited by admin on Fri Dec 15 15:34:11 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
1112
Created by
admin on Fri Dec 15 15:34:11 UTC 2023 , Edited by admin on Fri Dec 15 15:34:11 UTC 2023
|
PRIMARY | |||
|
33419-42-0
Created by
admin on Fri Dec 15 15:34:11 UTC 2023 , Edited by admin on Fri Dec 15 15:34:11 UTC 2023
|
PRIMARY | |||
|
CHEMBL44657
Created by
admin on Fri Dec 15 15:34:11 UTC 2023 , Edited by admin on Fri Dec 15 15:34:11 UTC 2023
|
PRIMARY | |||
|
3835
Created by
admin on Fri Dec 15 15:34:11 UTC 2023 , Edited by admin on Fri Dec 15 15:34:11 UTC 2023
|
PRIMARY | |||
|
1268808
Created by
admin on Fri Dec 15 15:34:11 UTC 2023 , Edited by admin on Fri Dec 15 15:34:11 UTC 2023
|
PRIMARY | |||
|
C491
Created by
admin on Fri Dec 15 15:34:11 UTC 2023 , Edited by admin on Fri Dec 15 15:34:11 UTC 2023
|
PRIMARY | |||
|
6517
Created by
admin on Fri Dec 15 15:34:11 UTC 2023 , Edited by admin on Fri Dec 15 15:34:11 UTC 2023
|
PRIMARY | |||
|
251-509-1
Created by
admin on Fri Dec 15 15:34:11 UTC 2023 , Edited by admin on Fri Dec 15 15:34:11 UTC 2023
|
PRIMARY | |||
|
6PLQ3CP4P3
Created by
admin on Fri Dec 15 15:34:11 UTC 2023 , Edited by admin on Fri Dec 15 15:34:11 UTC 2023
|
PRIMARY | |||
|
4179
Created by
admin on Fri Dec 15 15:34:11 UTC 2023 , Edited by admin on Fri Dec 15 15:34:11 UTC 2023
|
PRIMARY | RxNorm | ||
|
D005047
Created by
admin on Fri Dec 15 15:34:11 UTC 2023 , Edited by admin on Fri Dec 15 15:34:11 UTC 2023
|
PRIMARY | |||
|
m5199
Created by
admin on Fri Dec 15 15:34:11 UTC 2023 , Edited by admin on Fri Dec 15 15:34:11 UTC 2023
|
PRIMARY | Merck Index | ||
|
100000082091
Created by
admin on Fri Dec 15 15:34:11 UTC 2023 , Edited by admin on Fri Dec 15 15:34:11 UTC 2023
|
PRIMARY | |||
|
36462
Created by
admin on Fri Dec 15 15:34:11 UTC 2023 , Edited by admin on Fri Dec 15 15:34:11 UTC 2023
|
PRIMARY | |||
|
SUB07337MIG
Created by
admin on Fri Dec 15 15:34:11 UTC 2023 , Edited by admin on Fri Dec 15 15:34:11 UTC 2023
|
PRIMARY | |||
|
4911
Created by
admin on Fri Dec 15 15:34:11 UTC 2023 , Edited by admin on Fri Dec 15 15:34:11 UTC 2023
|
PRIMARY | |||
|
ETOPOSIDE
Created by
admin on Fri Dec 15 15:34:11 UTC 2023 , Edited by admin on Fri Dec 15 15:34:11 UTC 2023
|
PRIMARY | |||
|
DTXSID5023035
Created by
admin on Fri Dec 15 15:34:11 UTC 2023 , Edited by admin on Fri Dec 15 15:34:11 UTC 2023
|
PRIMARY | |||
|
DB00773
Created by
admin on Fri Dec 15 15:34:11 UTC 2023 , Edited by admin on Fri Dec 15 15:34:11 UTC 2023
|
PRIMARY | |||
|
ETOPOSIDE
Created by
admin on Fri Dec 15 15:34:11 UTC 2023 , Edited by admin on Fri Dec 15 15:34:11 UTC 2023
|
PRIMARY | Description: A white or almost white, crystalline powder.Solubility: Practically insoluble in water; sparingly soluble in methanol R; slightly soluble in ethanol (~750 g/l) TS and dichloromethane R.Category: Cytotoxic drug.Storage: Etoposide should be kept in a tightly closed container.Labelling: The designation Etoposide for parenteral use indicates that the substance complies with the additional requirementsand may be used for parenteral administration. Expiry date.Additional information:. CAUTION - Etoposide must be handled with care, avoiding contact with the skin and inhalation of airborne particles.Requirement: Etoposide contains not less than 98.0% and not more than the equivalent of 102.0% of C29H32O13, calculated with reference to the dried substance. | ||
|
6815
Created by
admin on Fri Dec 15 15:34:11 UTC 2023 , Edited by admin on Fri Dec 15 15:34:11 UTC 2023
|
PRIMARY | |||
|
6PLQ3CP4P3
Created by
admin on Fri Dec 15 15:34:11 UTC 2023 , Edited by admin on Fri Dec 15 15:34:11 UTC 2023
|
PRIMARY | |||
|
141540
Created by
admin on Fri Dec 15 15:34:11 UTC 2023 , Edited by admin on Fri Dec 15 15:34:11 UTC 2023
|
PRIMARY | |||
|
Etoposide
Created by
admin on Fri Dec 15 15:34:11 UTC 2023 , Edited by admin on Fri Dec 15 15:34:11 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TARGET -> INHIBITOR |
BINDING
|
||
|
TRANSPORTER -> SUBSTRATE |
|
||
|
TRANSPORTER -> SUBSTRATE | |||
|
TRANSPORTER -> SUBSTRATE | |||
|
TRANSPORTER -> INHIBITOR | |||
|
TRANSPORTER -> SUBSTRATE |
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLITE -> PARENT |
|
||
|
METABOLITE -> PARENT |
URINE
|
||
|
METABOLITE -> PARENT |
PLASMA; URINE
|
||
|
PRODRUG -> METABOLITE ACTIVE |
|
||
|
METABOLITE -> PARENT |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
IMPURITY -> PARENT |
|
||
|
IMPURITY -> PARENT |
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
||
|
IMPURITY -> PARENT |
|
||
|
IMPURITY -> PARENT |
|
||
|
IMPURITY -> PARENT |
|
||
|
IMPURITY -> PARENT |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|